Leorah Ross

2.3k citations

23 papers · 1.6k indexed · 1 hit paper · h-index 7

Impact in

Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment

Papers in

Physiology 21
- Lysosomal Storage Disorders Research 19
Organic Chemistry 11
- Carbohydrate Chemistry and Synthesis 11

Co-authors: George D. Yancopoulos Ella Ioffe John S. Rudge Nicole L. Glazer Susan D. Croll Gavin Thurston Donald M. McDonald Jocelyn Holash
Journals: Molecular Genetics and Metabolism (8 papers)Blood (7 papers)Nature Medicine (1 paper)Drug Safety (1 paper)New England Journal of Medicine (1 paper)
Partner nations: United States Russia Argentina

In The Last Decade

Leorah Ross

21 papers receiving 1.5k citations

Hit Papers

align trajectories log scale

Angiopoietin-1 protects the adult vasculature against plasma leakage 2000 · 1.1k citations

Peers

Countries citing papers authored by Leorah Ross

Since Specialization

Citations

This map shows the geographic impact of Leorah Ross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leorah Ross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leorah Ross more than expected).

Fields of papers citing papers by Leorah Ross

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leorah Ross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leorah Ross. The network helps show where Leorah Ross may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Leorah Ross, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Leorah Ross Line = papers co-authored together Leorah Ross links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Use of Identical INN “Imiglucerase” for Different Drug Products: Impact Analysis of Adverse Events in a Proprietary Global Safety Database Drug Safety ·L. A. George, María Dolores Chavero Blanco, Xueyan Han, Joan Keutzer, Helen T. Buckland, Leorah Ross, Hiroyuki TAKAKURA	2022	0
2	How a concentration-effect analysis of data from the eliglustat thorough electrocardiographic study was used to support dosing recommendations Molecular Genetics and Metabolism ·Jeremy N. Ruskin, Catherine Ortemann‐Renon, Jérôme Msihid, Leorah Ross, Ana Cristina Puga, Michel Peterschmitt, Gerald F. Cox, Pierre Maison‐Blanche	2020	6
3	Effects of paroxetine, ketoconazole, and rifampin on the metabolism of eliglustat, an oral substrate reduction therapy for Gaucher disease type 1 Molecular Genetics and Metabolism Reports ·李罗维, Gerald F. Cox, Jennifer Ibrahim, Michel Peterschmitt, Leorah Ross, Nathan Thibault, Bukhoriah Safitri	2020	6
4	Effect of eliglustat on the pharmacokinetics of digoxin, metoprolol, and oral contraceptives and absorption of eliglustat when coadministered with acid-reducing agents Molecular Genetics and Metabolism ·Nathan Thibault, Jennifer Ibrahim, Michel Peterschmitt, Ana Cristina Puga, Leorah Ross, 李罗维, Yong Xue, Bukhoriah Safitri	2020	5
5	Eliglustat compared with imiglucerase in patients with Gaucher's disease type 1 stabilised on enzyme replacement therapy: a phase 3, randomised, open-label, non-inferiority trial The Lancet ·Timothy M. Cox, Guillermo Drelichman, Sarah B. Mollo, Manisha Balwani, Thomas Andrew Burrow, Ana María Martins, Elena Lukina, Barry E. Rosenbloom, Leorah Ross, Jennifer Angell, Ana Cristina Puga	2015	118
6	Tremor and peripheral neuropathy are infrequent and non-serious events in Gaucher type 1 patients treated with eliglustat Molecular Genetics and Metabolism ·Heather Lau, Jennifer Ibrahim, Michel Peterschmitt, Leorah Ross	2015	4
7	ENGAGE — A phase 3, randomized, double-blind, placebo-controlled, multi-center study to investigate the efficacy and safety of eliglustat in adults with Gaucher disease type 1: Results after 18months Molecular Genetics and Metabolism ·Pramod K. Mistry, Dominick Amato, Majed Dasouki, Seymour Packman, Gregory M. Pastores, Sarit Assouline, Manisha Balwani, Andres Ortega, Suma P. Shankar, María Helena Solano, Leorah Ross, Jennifer Angell, Michel Peterschmitt	2015	8
8	ENCORE, a randomized, controlled, open-label non-inferiority study comparing eliglustat to imiglucerase in Gaucher disease type 1 patients stabilized on enzyme replacement therapy: 24-month results Molecular Genetics and Metabolism ·Timothy M. Cox, Guillermo Drelichman, Sarah B. Mollo, Manisha Balwani, Thomas Andrew Burrow, Ana Maria Martins, Elena Lukina, Barry E. Rosenbloom, Leorah Ross, Jennifer Angell, Michel Peterschmitt	2015	8
9	Eliglustat, an investigational oral therapy for Gaucher disease type 1: Phase 2 trial results after 4 years of treatment Blood Cells Molecules and Diseases ·Elena Lukina, Nora Watman, Marta Dragosky, Gregory M. Pastores, Elsa Ávila Arreguin, Hanna Rosenbaum, Ari Zimran, Jennifer Angell, Leorah Ross, Ana Cristina Puga, Aliakbar Eski	2014	61
10	Eliglustat safety profile based on a pooled analysis of data from four trials in Gaucher disease type I Molecular Genetics and Metabolism ·Leorah Ross, Aliakbar Eski, Ana Cristina Puga, Gerald F. Cox, Sachin Marulkar, Jennifer Angell, Fernanda de F. Rodrigues, Raymond Mankoski	2014	4
11	ENCORE: A randomized, controlled, open-label non-inferiority study comparing eliglustat to imiglucerase in Gaucher disease type 1 patients on enzyme replacement therapy who have reached therapeutic goals Molecular Genetics and Metabolism ·Timothy M. Cox, Guillermo Drelichman, Sarah B. Mollo, Manisha Balwani, Thomas Andrew Burrow, Ana Maria Martins, Elena Lukina, Barry E. Rosenbloom, Leorah Ross, Jennifer Angell, Ana Cristina Puga	2014	1
12	Encore - a Randomized, Controlled, Open-Label Non-Inferiority Study Comparing Eliglustat to Imiglucerase in Gaucher Disease Type 1 Patients Stabilized on Enzyme Replacement Therapy: 24-Month Results Blood ·Barry E. Rosenbloom, Timothy M. Cox, Guillermo Drelichman, Sarah B. Mollo, Manisha Balwani, Thomas Andrew Burrow, Ana María Martins, Elena Lukina, Leorah Ross, Jennifer Angell, Aliakbar Eski	2014	2
13	Engage - a Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Investigate the Efficacy and Safety of Eliglustat in Adults with Gaucher Disease Type 1: Results after 18 Months Blood ·Dominick Amato, Majed Dasouki, Seymour Packman, Gregory M. Pastores, Sarit Assouline, Manisha Balwani, Pramod K. Mistry, Andres Ortega, Suma P. Shankar, María Helena Solano, Leorah Ross, Jennifer Angell, Aliakbar Eski	2014	4
14	Encore: A Randomized, Controlled, Open-Label Non-Inferiority Study Comparing Eliglustat To Imiglucerase In Gaucher Disease Type 1 Patients On Enzyme Replacement Therapy Who Have Reached Therapeutic Goals Blood ·Manisha Balwani, Timothy M. Cox, Guillermo Drelichman, Sarah B. Mollo, Ana María Martins, Elena Lukina, Barry E. Rosenbloom, Leorah Ross, Jennifer Angell, Ana Cristina Puga	2013	5
15	Eliglustat, an Investigational Oral Therapy for Gaucher Disease Type 1: Phase 2 Results After 4 Years of Treatment Blood ·Michel Peterschmitt, Elena Lukina, Nora Watman, Marta Dragosky, Gregory M. Pastores, Elsa Ávila Arreguin, Hanna Rosenbaum, Ari Zimran, Marcella Guedes Pereira Gouvêa Bezerra, Rasha Aguzzi, Leorah Ross, Ana Cristina Puga	2012	2
16	Eliglustat, an Investigational Oral Therapy for Gaucher Disease Type 1 (GD1): Updated Phase 2 Results Molecular Genetics and Metabolism ·Michel Peterschmitt, Elena Lukina, Nora Watman, Marta Dragosky, Marcelo Iastrebner, Gregory M. Pastores, Elsa Ávila Arreguin, Mici Phillips, Hanna Rosenbaum, Marcella Guedes Pereira Gouvêa Bezerra, Rasha Aguzzi, Leorah Ross, Ana Cristina Puga	2012	1
17	Eliglustat, An Investigational Oral Therapy for Gaucher Disease Type 1: Phase 2 Results After 3 Years Blood ·Michel Peterschmitt, Elena Lukina, Nora Watman, Marta Dragosky, Marcelo Iastrebner, Gregory M. Pastores, Elsa Ávila Arreguin, Mici Phillips, Hanna Rosenbaum, Marcella Guedes Pereira Gouvêa Bezerra, Rasha Aguzzi, Leorah Ross, Ana Cristina Puga	2011	2
18	Improvements in Skeletal Manifestations in Gaucher Disease Type 1 Patients After 3 Years of Treatment with Oral Eliglustat During a Phase 2 Trial, Blood ·Michel Peterschmitt, Ravi S. Kamath, Elena Lukina, Nora Watman, Marta Dragosky, Marcelo Iastrebner, Gregory M. Pastores, Elsa Ávila Arreguin, Mici Phillips, Hanna Rosenbaum, Marcella Guedes Pereira Gouvêa Bezerra, Rasha Aguzzi, Leorah Ross, Ana Cristina Puga, Daniel I. Rosenthal	2011	1
19	Vascular endothelial growth factor-trap decreases tumor burden, inhibits ascites, and causes dramatic vascular remodeling in an ovarian cancer model. PubMed ·Annette T. Byrne, Leorah Ross, A. J. Stegink, Mikiye Nakanishi, Limin Hu, Andrés Anwandter, George D. Yancopoulos, Robert B. Jaffe	2003	248
20	Angiopoietin-1 protects the adult vasculature against plasma leakage Nature Medicine ·Gavin Thurston, John S. Rudge, Ella Ioffe, 何春来, Leorah Ross, Susan D. Croll, Nicole L. Glazer, Jocelyn Holash, Donald M. McDonald, George D. Yancopoulos Hit paper breakdown →	2000	1055

About Leorah Ross

Leorah Ross is a scholar working on Physiology, Organic Chemistry, Genetics, Immunology and Allergy and Cognitive Neuroscience, having authored 23 papers that have together received 1.6k indexed citations. Recurring topics across this work include Lysosomal Storage Disorders Research (19 papers), Carbohydrate Chemistry and Synthesis (11 papers), Glycosylation and Glycoproteins Research (7 papers), Trypanosoma species research and implications (3 papers), Autism Spectrum Disorder Research (3 papers), Child Nutrition and Feeding Issues (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Angiogenesis and VEGF in Cancer (2 papers). The work is most often cited by research in Cancer Research (266 citations), Reproductive Medicine (148 citations), Molecular Biology (931 citations), Immunology and Allergy (82 citations) and Physiology (285 citations). Leorah Ross has collaborated with scholars based in United States, Russia and Argentina. Frequent co-authors include George D. Yancopoulos, Ella Ioffe, John S. Rudge, Nicole L. Glazer, Susan D. Croll, Gavin Thurston, Donald M. McDonald, Jocelyn Holash, Annette T. Byrne and Limin Hu. Their work appears in journals such as Molecular Genetics and Metabolism, Blood, Nature Medicine, Drug Safety and New England Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact